Valneva Balance Sheet Health
Financial Health criteria checks 3/6
Valneva has a total shareholder equity of €217.5M and total debt of €172.6M, which brings its debt-to-equity ratio to 79.4%. Its total assets and total liabilities are €516.6M and €299.1M respectively.
Key information
79.4%
Debt to equity ratio
€172.58m
Debt
| Interest coverage ratio | n/a |
| Cash | €156.34m |
| Equity | €217.47m |
| Total liabilities | €299.15m |
| Total assets | €516.61m |
Recent financial health updates
No updates
Recent updates
Valneva seeking a partnership for next-gen COVID-19 vaccine
Sep 26Valneva shows booster effect of COVID shot against AstraZeneca vaccine
Aug 29Valneva launches up to $75M at-the-market ADS offering program
Aug 15Valneva: Vaccine Business, Catalysts Ahead, And Pfizer's Lyme Love
Aug 08Valneva agrees to cut COVID vaccine supplies to EU
Jul 20Financial Position Analysis
Short Term Liabilities: VALN's short term assets (€303.6M) exceed its short term liabilities (€109.2M).
Long Term Liabilities: VALN's short term assets (€303.6M) exceed its long term liabilities (€190.0M).
Debt to Equity History and Analysis
Debt Level: VALN's net debt to equity ratio (7.5%) is considered satisfactory.
Reducing Debt: VALN's debt to equity ratio has increased from 19.6% to 79.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VALN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if VALN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 08:54 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Valneva SE is covered by 25 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stéphan Dubosq | Arkeon Finance |
| Jean-Jacques Le Fur | Bryan Garnier & Co |
| Bruno Bulic | Bryan Garnier & Co |